Methods for the administration of iloperidone
DCFirst Claim
Patent Images
1. A method of decreasing a risk of QT prolongation in a patient being treated for schizophrenia with iloperidone, the method comprising:
- administering to the patient a dose of iloperidone that is 24 mg/day if, and because, the patient is not being treated with fluoxetine; and
administering to the patient a dose of iloperidone that is 12 mg/day if, and because, the patient is being treated with fluoxetine.
1 Assignment
Litigations
1 Petition
Accused Products
Abstract
The present invention relates to methods for treating a patient with iloperidone or a metabolite thereof, which patient is also being treated with fluoxetine, and lowering risk for QT prolongation.
26 Citations
1 Claim
-
1. A method of decreasing a risk of QT prolongation in a patient being treated for schizophrenia with iloperidone, the method comprising:
-
administering to the patient a dose of iloperidone that is 24 mg/day if, and because, the patient is not being treated with fluoxetine; and administering to the patient a dose of iloperidone that is 12 mg/day if, and because, the patient is being treated with fluoxetine.
-
Specification